Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TEL AVIV, March 09, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative...
-
Initial shipment of combat-proven systems delivered under an $8M defense contract (expandable to $25M) with a government defense customer in the Middle East, with production ramp underway to fulfill...
-
Hong Kong, TX, March 09, 2026 (GLOBE NEWSWIRE) -- Powell Max Limited (Nasdaq: PMAX) (“Powell Max” or the “Company”), a financial communications services provider, is pleased to provide the...
-
March 9, 2026 Biodexa Announces Support for Life’s a Polyp FoundationFirst U.S. Patient Advocacy Group for FAP Patients Cardiff, UK – March 9, 2026 – Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a...
-
Austin, United States, March 09, 2026 (GLOBE NEWSWIRE) -- Pharmacogenomics Market Size & Growth Analysis: According to SNS Insider, The Pharmacogenomics Market was valued at USD 8.07 Billion in...
-
ROCHESTER, NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical technologies for defense tech and other vibrant end-markets, today...
-
Agreement Provides for Sale and Promotion of Private Communications Solutions in Ecuador Tel Aviv, Israel, March 09, 2026 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”)...
-
AVAX One CEO Jolie Kahn To Participate in a Fireside Chat on March 18 WEST PALM BEACH, FL, March 09, 2026 (GLOBE NEWSWIRE) -- AVAX One Technology Ltd. (Nasdaq: AVX) (“AVAX One” or the "Company"),...
-
Warsaw, Poland, March 09, 2026 (GLOBE NEWSWIRE) -- Brighty, the European crypto-native digital finance platform, announces the launch of its Banking API for AI Agents. It’s a developer-ready...
-
CDI-988 is a direct-acting, oral antiviral being developed for norovirusNorovirus challenge study is underway at Emory University School of Medicine to evaluate efficacy and safety of CDI-988 No...